case_images: PMC8238616_01
case_images: MRI of the liver with contrast showing a sizable hemorrhagic HA measuring 9.0 x 8.5 cm and adjacent nonhemorrhagic HA 5.9 x 5.1 cm (segment 4) and several HAs smaller than 5 cm in diameter.
case_images: CRIGM2021-9963440.001.jpg
case_images: PMC8238616_01_CRIGM2021-9963440.001.jpg
case_images: fig1
case_images: Another one was a nonhemorrhagic lesion 5.9 x 5.1 cm, inseparable from the dominant mass (Figure 1).
case_images: (a) Subselective catheterization of the hepatic artery, segment 8 branch with arteriography. (b) Cone beam CT demonstrating patency and perfusion of the hepatic adenoma. (c) Coil embolization of segment 8 branch of the hepatic artery.
case_images: CRIGM2021-9963440.002.jpg
case_images: PMC8238616_01_CRIGM2021-9963440.002.jpg
case_images: fig2
case_images: The emergent transarterial embolization of the lesion was performed, considering rapid expansion and life-threatening hemorrhage risk (Figure 2).
case_images: CT scan of the abdomen performed the next day after embolization showing the decrease in the dominant lesion size to 8.0 x 7.9 cm.
case_images: CRIGM2021-9963440.003.jpg
case_images: PMC8238616_01_CRIGM2021-9963440.003.jpg
case_images: fig3
case_images: The CT scan completed the next day showed a decrease of adenoma to 8.0 cm x 7.9 cm (Figure 3) along with the increase in hemoglobin levels, confirming the successful embolization.
case_images: CT scan of the abdomen repeated in two months showing that the dominant HA decreased in size, measuring 7.1 x 5.7 cm, with coils and a resolved hemorrhagic component. The nonhemorrhagic mass in segment four decreased to 4.2 cm in diameter.
case_images: CRIGM2021-9963440.004.jpg
case_images: PMC8238616_01_CRIGM2021-9963440.004.jpg
case_images: fig4
case_images: It showed a decrease in the size of the dominant lesion with a complete resolution of the hemorrhagic component (Figure 4).